Breakthrough in Photocatalytic Cancer Therapy Offers New Hope for Precision Tumor Treatment
A team of researchers at the Korea Institute of Science and Technology has made a groundbreaking discovery in the field of nanotechnology and photocatalysis, developing a novel approach to cancer therapy. By harnessing photocatalytic reactions, the team has created a spatiotemporally controllable photocatalytic cancer therapy that has shown remarkable tumor-suppressing capabilities. This innovative solution uses a photoinduced plasmon electron transfer (PiPET)-based bioorthogonal cleavage reaction to achieve precise control over the treatment.
Key Takeaways:
- The research team, led by Dohyub Jang, has developed a novel approach to cancer therapy using photocatalytic reactions, which has shown significant enhancements in catalytic activity and tumor-suppressing capabilities.
- The photocatalytic cancer therapy utilizes a photoinduced plasmon electron transfer (PiPET)-based bioorthogonal cleavage reaction to achieve precise spatiotemporal control over the treatment.
- The therapy has demonstrated remarkable tumor-suppressing capabilities in both in vitro and in vivo studies, with a ninefold increase in the release of allyl carbamate-conjugated methylene blue.
- The research has been extensively peer-reviewed and published in the journal Advanced Materials.
- The Korea Institute of Science and Technology is one of the leading research institutions in South Korea, and this breakthrough is a testament to their commitment to advancing the field of nanotechnology and photocatalysis.
Statistics:
- The photocatalytic cancer therapy has shown a ninefold increase in the release of allyl carbamate-conjugated methylene blue.
- In vitro and in vivo studies have demonstrated the remarkable tumor-suppressing capabilities of the bioorthogonal system.
- The therapy has been shown to be highly effective in preventing leuko-MB formation.
- The photoinduced plasmon electron transfer (PiPET)-based bioorthogonal cleavage reaction has demonstrated significant enhancements in catalytic activity.
Sources:
- Korea Institute of Science and Technology. Photoinduced Plasmon Electron Transfer-based Bioorthogonal Cleavage Reaction for Precision Tumor Therapy. Advanced Materials, 2025.
- NewsRx. Korea Institute of Science and Technology Reports Findings in Photocatalytics (Photoinduced Plasmon Electron Transfer-based Bioorthogonal Cleavage Reaction for Precision Tumor Therapy). Nanotechnology Weekly. July 14, 2025; p 1780.
- Wiley-Blackwell. Advanced Materials. onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4095
- Korea Institute of Science and Technology. Chemical and Biological Integrative Research Center. Hwarang-ro 14-Gil, Seongbuk-gu, Seoul, 02792, South Korea.